Latest filing published 16 Aug 2024 for Biora Therapeutics, INC., €17k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Eric dEsparbes span 2 companies, the busiest being Biora Therapeutics, Inc. and Innoviva, Inc. Over a trading history stretching from 14 January 2016 to 15 August 2024, the count stands at 14 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 16 August 2024: a share grant of €17k, in Biora Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations